Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1367466 | Bioorganic & Medicinal Chemistry Letters | 2006 | 5 Pages |
A series of novel pyrrolocarbazole lactams was identified as potent PARP-1 inhibitors in vitro and in a PC12 cellular NAD+ depletion assay. The SAR trends of substituents at the 3-position, as well as the effect of blocking the indole or lactam NH-groups of the template by methylation or formylation, are discussed in relation to molecular modeling studies.
Graphical abstractA series of novel pyrrolocarbazole lactams was identified as potent PARP-1 inhibitors in vitro and in a PC12 cellular NAD+ depletion assay. The SAR trends of substituents at the 3-position, as well as the effect of blocking the indole or lactam NH-groups of the template by methylation or formylation, are discussed in relation to molecular modeling studies.Figure optionsDownload full-size imageDownload as PowerPoint slide